Procore is a biotechnology company singly focused on developing solutions that improve the quality of lives of patients suffering from joint and bone diseases. The company’s flagship RegenoGel family is based on proprietary HAProLink technology, a platform technology that links hyaluronic acid to a protein of choice to create a microenvironment for the body to heal itself via natural, gentle cartilage and bone regeneration. RegenoGel products are approved by Israel’s Ministry of Health and have been commercially available since 2016. RegenoGel and the company’s platform technologies are based on the seminal work in biomimetic innovation of Prof. Avner Yayon’s, Procore’s founder.
Looking for a particular ProCore Ltd employee's phone or email?
The ProCore Ltd annual revenue was $5.8 million in 2026.
Eldad Ophir is the CFO of ProCore Ltd.
4 people are employed at ProCore Ltd.
ProCore Ltd is based in Ness Ziona, Central District.
The NAICS codes for ProCore Ltd are [32, 325, 3254].
The SIC codes for ProCore Ltd are [28, 80, 283].